Patricia E. Cole

Phase II study of the halichondrin B analog eribulin mesylate in patients with locally advanced or metastatic breast cancer previously treated with an anthracycline, a taxane, and capecitabine.

R. Paridaens, J. Wanders, M. Campone, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

In Vitro and In Vivo Comparison of 3,2-HOPO Versus Deferoxamine-Based Chelation of Zirconium-89 to the Antimesothelin Antibody Anetumab

P. Choyke, A. Cuthbertson, J. Roy, 2021, Cancer biotherapy & radiopharmaceuticals.

Phase II study of eribulin mesylate, a halichondrin B analog, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane.

David A. Smith, A. Tan, C. Fabian, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I dose escalation and pharmacokinetic study of enzastaurin, an oral protein kinase C beta inhibitor, in patients with advanced cancer.

R. Herbst, M. Truong, M. Carducci, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

89Zr-3,2-HOPO-Mesothelin Antibody PET Imaging Reflects Tumor Uptake of Mesothelin-Targeted 227Th-Conjugate Therapy in Mice

E. de Vries, L. Broer, A. Cuthbertson, 2022, The Journal of Nuclear Medicine.

Comparison of Cerebral Blood Flow in Regions Relevant to Cognition After Enzalutamide, Darolutamide, and Placebo in Healthy Volunteers: A Randomized Crossover Trial

O. O'Daly, S. Williams, Fiona Patrick, 2023, Targeted Oncology.

Preclinical characterization of [18F]T-008, a novel PET imaging radioligand for cholesterol 24-hydroxylase

J. Seibyl, G. Tamagnan, O. Barret, 2021, European Journal of Nuclear Medicine and Molecular Imaging.

A phase II study of eribulin mesylate (E7389) in patients with advanced, previously treated non-small-cell lung cancer.

A. Das, N. Iannotti, N. Gabrail, 2012, Clinical lung cancer.

Radiation dosimetry and biodistribution of [18F]PF-05270430, a radiotracer for phosphodiesterase 2A (PDE2A) in rhesus macaques and humans

D. Jennings, J. Seibyl, K. Marek, 2018 .